AzTrials
AzTrials

Older Adults (60 - 85 Years Old)NCT07459153

Multiple Breathing Training on Pulmonary Function and Respiratory Muscle Strength in Older Adults

A study testing Multiple breathing training in people with Older Adults (60 - 85 Years Old), run by Chulalongkorn University at 1 site in Thailand.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study were to investigate the effects of multiple breathing training on pulmonary function, respiratory muscle strength, chest expansion, fractional exhaled nitric oxide (FeNO), aerobic capacity, and dyspnea symptoms in older adults. Read more about this study

Who is it for?
Ages 60 to 75 yearsHealthy volunteers can take part
Conditions the study is for
Older Adults (60 - 85 Years Old)
What is being tested?
Multiple breathing training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
26 participants
Where
1 siteThailand
Study dates
1 Nov 2025to 30 Mar 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 to 75 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Older adults aged 60-75 years, both male and female.
  • Not regularly physically active (exercising fewer than 2 times per week) during the 6 months prior to the study.
  • Cooperative, without communication problems, and able to follow instructions from the trainer.
  • No history of cardiovascular disease and no respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), etc.
  • No hypertension, or if diagnosed with hypertension, it must be well controlled, with resting blood pressure not exceeding 140 mmHg systolic and 90 mmHg diastolic.
  • Able to ambulate independently without assistance or assistive devices.
  • Willing to participate in the study and able to provide written informed consent.

Who cannot join

  • Any unforeseen events preventing continued participation in the study, such as injury from an accident or illness.
  • Attendance of less than 80% of the training sessions (fewer than 19 out of 24 sessions, including the basic training period).
  • Withdrawal of consent or unwillingness to continue participation in the study.

Trial locations and contacts

1 site in 1 country.

Thailand1 site
  • Faculty of Sports Science, Chulalongkorn University

    Bangkok, Bangkok, 10330

Other trials in Thailand

About this study

Official title: Effects of Multiple Breathing Training on Pulmonary Function and Respiratory Muscle Strength in Older Adults

This study were to investigate the effects of multiple breathing training on pulmonary function, respiratory muscle strength, chest expansion, fractional exhaled nitric oxide (FeNO), aerobic capacity, and dyspnea symptoms in older adults.

Read the detailed description

The study included 26 male and female older adults aged 60-75 years, who were divided into a control group (n = 13) that maintained usual daily activities and an experimental group (n = 13) that received multiple breathing training.

The independent variable was multiple breathing training. Dependent variables included lung function (FVC, FEV₁, FEV₁/FVC, MVV), respiratory muscle strength (MIP, MEP), chest expansion, fractional exhaled nitric oxide (FeNO), aerobic capacity, and dyspnea assessment.

Being tested
Multiple breathing training
Keywords
Multiple breathing training, Pulmonary function, Respiratory muscle strength, Chest Expansion, Fractional Exhaled Nitric Oxide

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Multiple breathing trainingOther

    The multiple breathing training program consisted of five structured breathing exercises designed to improve inspiratory muscle strength, expiratory muscle strength, and breath control. Each exercise was performed for three sets, and the total training duration was approximately 40 minutes per session.

    The program included the following components:

    Inspiratory Muscle Training (PowerBreathe device): Participants performed resisted inhalation to strengthen the inspiratory muscles (10 repetitions per set).

    Expiratory Muscle Training (Balloon with control device): Participants exhaled into a balloon while maintaining pressure according to their measured maximal expiratory pressure (MEP) (10 repetitions per set).

    Inspiratory Training (Tri-Flow device): Participants inhaled through the device to elevate and maintain the floating balls, promoting sustained inspiratory effort (10 repetitions per set).

    Expiratory Training (Windmill device): Participants exhaled to rotate the windmill, e

Study groups in NCT07459153
Study groupRoleWhat they receive
Multiple breathing trainingExperimentalThe multiple breathing training program consisted of five structured breathing exercises designed to improve inspiratory muscle strength, expiratory muscle strength, and breath control. Each exercise was performed for three sets, and the total training duration was approximately 40 minutes per session. The program included the following components: Inspiratory Muscle Training (PowerBreathe device): Participants performed resisted inhalation to strengthen the inspiratory muscles (10 repetitions per set). Expiratory Muscle Training (Balloon with control device): Participants exhaled into a balloon while maintaining pressure according to their measured maximal expiratory pressure (MEP) (10 repetitions per set). Inspiratory Training (Tri-Flow device): Participants inhaled through the device to elevate and maintain the floating balls, promoting sustained inspiratory effort (10 repetitions per set). Expiratory Training (Windmill device): Participants exhaled to rotate the windmill,
Receives: Other: Multiple breathing training
Control group (Normal daily life)No interventionNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Forced Vital Capacity; FVC

    Participants were seated in a chair and wore a nasal clip during the assessment. They first performed three cycles of slow, normal breathing, followed by a demonstration of forced inspiration and expiration, and then returned to normal breathing.

    Measured: Change from Baseline FVC at 8 weeks.

  2. Forced Expiratory Volume in One second; FEV1

    Participants were seated in a chair and wore a nasal clip during the assessment. They first performed three cycles of slow, normal breathing, followed by a demonstration of forced inspiration and expiration, and then returned to normal breathing.

    Measured: Change from Baseline FEV1 at 8 weeks.

  3. Maximum Voluntary Ventilation; MVV

    Participants were instructed to breathe in and out as quickly and forcefully as possible for 15 seconds.

    Measured: Change from Baseline MVV at 8 weeks.

  4. Maximal Inspiratory Pressure; MIP

    Participants were instructed to exhale fully to functional residual capacity (FRC), then place the mouthpiece securely and perform a maximal inspiratory effort sustained for 1-2 seconds.

    Measured: Change from Baseline MIP at 8 weeks.

  5. Maximal expiratory pressure; MEP

    Participants inhaled fully to total lung capacity (TLC), maintained a tight seal on the mouthpiece, and then performed a maximal expiratory effort for 1-2 seconds.

    Measured: Change from Baseline MEP at 8 weeks.

Secondary outcomes (4)
  1. Chest expansion

    Participants were instructed to sit upright with their hands placed on their hips. They were then asked to perform a maximal exhalation followed by a maximal inhalation. The researcher measured chest expansion using a measuring tape at the following anatomical levels: upper chest: at the axillary line, midway between the 2nd and 4th ribs, middle chest: at the level of the xiphoid process, midway between the 4th and 6th ribs, and lower chest: at the level of the 10th rib.

    Measured: Change from Baseline Chest expansion at 8 weeks.

  2. Fraction exhaled nitric oxide; FeNO

    FeNO Monitor (BedFont, UK) was used to measure the FeNO. The participants inhaled deeply for 2 to 3 seconds before exhaling slowly, which normally took 10 seconds.

    Measured: Change from Baseline FeNO at 8 weeks.

  3. Six minutes walk test (6MWT)

    They were instructed to walk back and forth along a 30-meter walkway for six minutes at their usual, comfortable pace. The researcher marked the course every 3 meters and placed traffic cones at the turning points. Heart rate was monitored during the test, and the level of perceived exertion was assessed every minute. The total distance walked in six minutes was recorded for analysis.

    Measured: Change from Baseline 6MWT at 8 weeks.

  4. The University of California, SanDiego Shorthess of Breath Questionnaire (SOBQ)

    Participants completed a six-item dyspnea questionnaire before and after the intervention. Each item was rated on a 0-5 scale, with a maximum total score of 30 points. Scores were interpreted as follows: 0-10 indicated no to mild breathlessness, 11-20 indicated mild to moderate breathlessness, and 21-30 indicated moderate to severe breathlessness.

    Measured: Change from Baseline SOBQ at 8 weeks.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Mar 2026
  2. Study start1 Nov 2025
  3. Primary completion30 Mar 2026
  4. Study completion30 Mar 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
26 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07459153
Sponsor's protocol ID
EX PHYSIO SPSC 13
Status last verified
Mar 2025
First submitted
4 Mar 2026
Last updated
8 Oct 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Jansang S, Mickleborough T, Suksom D. Effects of Pursed-Lip Breathing Exercise Using Windmill Toy on Lung Function and Respiratory Muscle Strength in the Elderly. J Med Assoc Thai. 2016 Sep;99(9):1046-51.

    PubMed 29927211
  • Jun HJ, Kim KJ, Nam KW, Kim CH. Effects of breathing exercises on lung capacity and muscle activities of elderly smokers. J Phys Ther Sci. 2016 Jun;28(6):1681-5. doi: 10.1589/jpts.28.1681. Epub 2016 Jun 28.

    PubMed 27390394
  • Gosselink R. Breathing techniques in patients with chronic obstructive pulmonary disease (COPD). Chron Respir Dis. 2004;1(3):163-72. doi: 10.1191/1479972304cd020rs.

    PubMed 16281658
  • Chung Y, Huang TY, Liao YH, Kuo YC. 12-Week Inspiratory Muscle Training Improves Respiratory Muscle Strength in Adult Patients with Stable Asthma: A Randomized Controlled Trial. Int J Environ Res Public Health. 2021 Mar 22;18(6):3267. doi: 10.3390/ijerph18063267.

    PubMed 33809922
  • Hess A, Yu L, Klein I, De Mazancourt M, Jebrak G, Mal H, Brugiere O, Fournier M, Courbage M, Dauriat G, Schouman-Clayes E, Clerici C, Mangin L. Neural mechanisms underlying breathing complexity. PLoS One. 2013 Oct 3;8(10):e75740. doi: 10.1371/journal.pone.0075740. eCollection 2013.

    PubMed 24098396

Questions about this trial

What is this clinical trial studying?

A study testing Multiple breathing training in people with Older Adults (60 - 85 Years Old), run by Chulalongkorn University at 1 site in Thailand.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Thailand. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Forced Vital Capacity; FVC (time frame: Change from Baseline FVC at 8 weeks.). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07459153, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in